Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
58,378,537
-
Share change
-
+286,713
-
Total reported value
-
$2,626,676,199
-
Put/Call ratio
-
76%
-
Price per share
-
$45.00
-
Number of holders
-
173
-
Value change
-
+$33,782,408
-
Number of buys
-
95
-
Number of sells
-
80
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2019
As of 30 Jun 2019,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,378,537 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., FMR LLC, STATE STREET CORP, ORBIMED ADVISORS LLC, and GREAT POINT PARTNERS LLC.
This page lists
173
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.